Skip to content

Adapted ERAS in Gynecologic Oncology Surgery

Effectiveness of Adapted Enhanced Recovery After Surgery Protocol in Open Gynecologic Oncology Surgery: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04201626
Enrollment
200
Registered
2019-12-17
Start date
2020-06-01
Completion date
2022-02-28
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital Neoplasm Malignant Female

Brief summary

Background: In recent decades, the new concept of Enhanced Recovery After Surgery (ERAS) program has been well accepted in the fields of gynecologic surgery. Many studies have shown the effectiveness of ERAS protocol in reducing hospital's length of stay, patient's morbidity, and rate of postoperative complications while cutting back on health care cost. Thus, standard guidelines such as ACOG has strongly recommended ERAS protocol implementation into each institution. However, institutions have self-limitations on adapting the standard ERAS pathway published from ERAS society due to the demand in resources. The concept of partial implementation of ERAS protocol has been raised and was mentioned in guidelines that ERAS implementation should be individualized to each institution. Nevertheless, the effectiveness of adapted ERAS protocol itself has not been well researched. Objectives: To examine the effect of partial implementation of ERAS protocol adapted to our institution on patient's recovery (based on hospital length of stay, pain score, time to flatulence, postoperative complications, and re-visits) compared to standard routine care in women diagnosed with gynecologic malignancy (cervix, endometrium, and ovary) undergoing elective open surgery. Design: A randomized controlled trial in gynecologic cancers (cervix, endometrium, and ovary) women, age 18-75 years, undergoing elective open gynecologic oncology surgery at Faculty of Medicine, Chiang Mai University hospital. The participants will be randomly assigned into one of two study groups: intervention (adapted ERAS protocol) and control (standard routine care). For the intervention group, each woman will be brought through the adapted ERAS protocol step by step starting from preoperative counseling and preparation, intraoperative management, and postoperative management standard according to the adapted ERAS protocol. For the control group, each woman will be cared for using routine standard care. The primary outcome is length of hospital stay. 1.3 Proposed duration 24 Months

Interventions

PROCEDUREAdapted ERAS

Each woman in the intervention group will attend a preoperative counseling session with nurse and doctors. In addition to the standard preoperative counseling, explaining the purpose, process, and the importance of ERAS protocol compliance will be added to the session. Preoperative nutrition and laboratory assessment will be done according to adapted ERAS protocol on that same visit. During admission, the intervention group participants are provided with care according to adapted ERAS protocol including no bowel preparation, no extended fasting before surgery, balanced intravenous crystalloid, thromboprophylaxis, multimodal pain control reducing opioid usage, multimodal anti-emetics medications, stepping diet up to regular diet within 24 hours, chewing gum for post-operative ileus prevention, early removal of Foley's catheter, and promote early ambulation using care checklist plan.

Sponsors

Chiang Mai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* 18 - 75 years old * Diagnosed with gynecologic malignancy of cervix, endometrium, or ovary * Elective laparotomy surgery

Exclusion criteria

* Intraoperative accidental injury to urinary or GI organs * Retain endotracheal intubation after surgery * Peritoneal drainage for monitoring of bleeding/infection * Unable to follow oral instructions * Severe neuromuscular disease * Preoperative hyperalimentation * Neoadjuvant chemotherapy within 3 weeks prior to the procedure * Previous abdominal/pelvic radiation * Bowel obstruction * Emergency operation

Design outcomes

Primary

MeasureTime frameDescription
Length of hospital stayThrough hospital discharge, an average of 5 daysLength of hospital stay after surgery

Countries

Thailand

Contacts

Primary ContactKittipat Charoenkwan, MD, MSc
kittipat.c@cmu.ac.th+66-81-9920845

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026